Abstract
Secretory component (SC) acts as a transmembrane polymeric immunoglobulin receptor of epithelial cells and is known to bind to polymeric IgA and to contribute to the secretion of secretory IgA (sIgA). We describe a new biological function for free SC (FSC) by which the expression of intercellular adhesion molecule-1 (ICAM-1) and HLA-DR induced by interferon gamma (IFNγ) is inhibited in human keratinocytes. This activity coincided with suppression of adenosine cyclic 3,5-monophosphate (cyclic AMP) production in keratinocytes. Keratinocytes produced SC after stimulation with IFNγ and this production was suppressed by the addition of H-7 or propranolol. The addition of propranolol resulted in prolongation of ICAM-1 expression on keratinocytes induced by IFNγ. These results suggest that endogenously produced SC, as well as exogenously added FSC, acts as an inhibitor of IFNγ. Therefore, our results suggest that SC plays an antiinflammatory role in the pathogenesis of inflammatory skin diseases via inhibition in keratinocytes of IFNγ induced expression of ICAM-1 and HLA-DR.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mostov K (1991) The polymeric immunoglobulin receptor. Semin Cell Biol 2: 411–418
Kaneko F, Gushiken H, Kawagishi I, Miura Y, Kobayashi K, Kondo T (1980) Analysis of immunological responses in psoriatic lesions: (1) Immunopathological studies on psoriatic lesions. J Invest Dermatol 75: 436–439
Kaneko F, Kawagishi I, Miura Y, Kobayashi K (1982) Secretory IgA in skin and the adjacent mucous membranes. J Dermatol 9: 99–106
Huff JC (1990) Epithelial polymeric immunoglobulin receptors. J Invest Dermatol 94: 74S-78S
Krajci P, Kvale D, Tasken K, Brandtzaeg P (1992) Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor). Eur J Immunol 22: 2309–2315
Sollid LM, Kvale D, Brandtzaeg P, Markussen G, Thorsby E (1987) Interferon-γ enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol 138: 4303–4306
Kvale D, Lovhaug D, Sollid LM, Brandtzaeg P (1988) Tumor necrosis factor-α up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol 140: 3086–3089
Phillips JO, Everson MP, Moldoveanu Z, Lue C, Mestecky J (1990) Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol 145: 1740–1744
Lucisano-Valim YM, Lachmann PJ (1991) The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systemic study using chimeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol 84: 1–8
Takematsu H, Tagami H (1993) Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 129: 74–80
Bergh K, Iversen OJ, Lysvand H (1993) Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales. Arch Dermatol Res 285: 131–134
Wilson T, Christie DL (1991) Gravidin, an endogenous inhibitor of phospholipase A2 activity, is a secretory component of IgA. Biochem Biophys Res Commun 176: 447–452
Fernandez-Botran R (1991) Soluble cytokine receptors: their role in immunoregulation. FASEB J 5: 2567–2574
Maruyama K, Zhang JZ, Nihei Y, Ono I, Kaneko F (1994) Regulatory effects of antipsoriatic agents on interleukin-1α production by human keratinocytes stimulated with gamma interferon in vitro. Skin Pharmacol (in press)
Kobayashi K (1971) Studies on human secretory IgA. Comparative studies of the IgA-bound secretory piece and the free secretory piece protein. Immunochemistry 8: 785–800
Kusama K, Takahashi T, Asano M, Iwase T, Saito T, Nagasaki Y, Moro I (1989) Murine monoclonal antibody to secretory component. Jpn J Oral Biol 31: 471–473
Young IT (1977) Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25: 935–941
Rivas JM; Ullrich SE (1992) Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes: an essential role for keratinocyte-derived IL-10. J Immunol 149: 3865–3871
Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127: 871–881
Nickoloff BJ, Mitra RS (1992) Intraepidermal psoriatic cytokine network involves gamma interferon, transforming growth factor-alpha, and their cell surface receptors: dysregulation rather than deficiency. J Invest Dermatol 99: 882–883
Bouillon M, Fortier MA, Boulianne R, Audette M (1992) Biphasic effect of cAMP-elevating agents on ICAM-1 expression stimulated by retinoic acid and interferon-γ. Int J Cancer 50: 281–288
Steinkraus V, Steinfath M, Mensing H (1992) Beta-adrenergic blocking drugs and psoriasis. J Am Acad Dermatol 27: 266–267
Wiley HE, Weinstein GD (1979) Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo. J Invest Dermatol 73: 545–547
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nihei, Y., Maruyama, K., Zhang, J.Z. et al. Secretory component (polymeric immunoglobulin receptor) as an intrinsic inhibitor of biological functions of interferon gamma in keratinocytes. Arch Dermatol Res 287, 546–552 (1995). https://doi.org/10.1007/BF00374074
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00374074